Organoids are three-dimensional cell cultures that self-organize into structures resembling aspects of organs or tissues. They are typically derived from stem cells, progenitor cells, or patient tissue and can reproduce selected features such as cell diversity, architecture, differentiation, and function. In biotechnology and nanomedicine, organoids are used to model development, disease, infection, cancer, regeneration, and drug response in systems more complex than conventional two-dimensional culture.
Organoids matter because they provide human-relevant models for biomedical research, personalized medicine, toxicology, and therapeutic discovery. They are studied in brain, gut, liver, kidney, lung, pancreas, retina, and tumor models, often using patient-derived material. Key challenges include reproducibility, vascularization, immune components, maturation, scalability, and integration with analysis platforms. The field connects closely to organ-on-chip, microphysiological systems, tissue engineering, and drug screening.
Conferences on organoids appear in stem-cell biology, biotechnology, regenerative medicine, cancer research, drug discovery, and biomedical engineering programs. Sessions often cover disease modeling, organoid biobanks, organoid-on-chip systems, genome editing, high-throughput screening, and clinical translation. Tracking organoid events helps researchers follow a fast-growing field where self-organizing tissues are changing experimental biology and medicine.
To learn more, read our detailed glossary article on organoids.